ERGIC1 Antikörper

Produktnummer ABIN5577496

Produktdetails anti-ERGIC1 Antikörper

Target: ERGIC1 (Endoplasmic Reticulum-Golgi Intermediate Compartment (ERGIC) 1 (ERGIC1))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ERGIC1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Verwendungszweck: Rabbit polyclonal antibody raised against recombinant ERGIC1.

Sequenz: PGNFHVSTHS ATAQPQNPDM THVIHKLSFG DTLQVQNIHG AFNALGGADR LTSNPLASHD YIL

Kreuzreaktivität: Human

Immunogen: Recombinant protein corresponding to amino acids of human ERGIC1.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Immunohistochemistry (1:50-1:200)
Western Blot (1:250-1:500)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In PBS, pH 7.2 (40 % glycerol, 0.02 % sodium azide)

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Details zu ERGIC1

Target: ERGIC1 (Endoplasmic Reticulum-Golgi Intermediate Compartment (ERGIC) 1 (ERGIC1))

Andere Bezeichnung: ERGIC1 (ERGIC1 Produkte)

Synonyme: ERGIC-32 antikoerper, ERGIC32 antikoerper, NET24 antikoerper, 1200007D18Rik antikoerper, maa-136 antikoerper, ergic32 antikoerper, endoplasmic reticulum-golgi intermediate compartment 1 antikoerper, endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 antikoerper, endoplasmic reticulum-golgi intermediate compartment 1 S homeolog antikoerper, Ergic1 antikoerper, ERGIC1 antikoerper, ergic1.S antikoerper

Hintergrund: Full Gene Name: endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1
Synonyms: ERGIC-32,ERGIC32,FLJ39864,KIAA1181,MGC14345

Gen-ID: 57222

Pathways: SARS-CoV-2 Protein Interaktom